| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.26 | 4e-08 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 7e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |